{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:04:59Z","timestamp":1790849099511,"version":"4.1.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T00:00:00Z","timestamp":1621209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T00:00:00Z","timestamp":1621209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The mechanisms driving therapeutic resistance and poor outcomes of mantle cell lymphoma (MCL) are incompletely understood. We characterize the cellular and molecular heterogeneity within and across patients and delineate the dynamic evolution of tumor and immune cell compartments at single cell resolution in longitudinal specimens from ibrutinib-sensitive patients and non-responders. Temporal activation of multiple cancer hallmark pathways and acquisition of 17q are observed in a refractory MCL. Multi-platform validation is performed at genomic and cellular levels in PDX models and larger patient cohorts. We demonstrate that due to 17q gain, BIRC5\/survivin expression is upregulated in resistant MCL tumor cells and targeting BIRC5 results in marked tumor inhibition in preclinical models. In addition, we discover notable differences in the tumor microenvironment including progressive dampening of CD8+ T cells and aberrant cell-to-cell communication networks in refractory MCLs. This study reveals diverse and dynamic tumor and immune programs underlying therapy resistance in MCL.<\/jats:p>","DOI":"10.1038\/s41467-021-22872-z","type":"journal-article","created":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T06:04:53Z","timestamp":1621231493000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5760-5797","authenticated-orcid":false,"given":"Shaojun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3778-4438","authenticated-orcid":false,"given":"Vivian Changying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9277-2507","authenticated-orcid":false,"given":"Guangchun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dapeng","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwei","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingsong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1006-6866","authenticated-orcid":false,"given":"Rongjia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghao","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enyu","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9754-0967","authenticated-orcid":false,"given":"Yuanxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Badillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Leeming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Hartig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Bigcal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2811-1090","authenticated-orcid":false,"given":"Jia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Kanagal-Shamanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6822-7880","authenticated-orcid":false,"given":"Chi Young","family":"Ok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael E.","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5412-9860","authenticated-orcid":false,"given":"Jianhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingzhi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjit","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sairah","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma","family":"Rodriquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selvi","family":"Thirumurthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preetesh","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaus","family":"Wagner-Bartak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3642-1897","authenticated-orcid":false,"given":"Holly","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystle","family":"Nomie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Flowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8663-2671","authenticated-orcid":false,"given":"Andrew","family":"Futreal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9380-0266","authenticated-orcid":false,"given":"Linghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9748-5486","authenticated-orcid":false,"given":"Michael","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,17]]},"reference":[{"key":"22872_CR1","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1182\/blood.V89.6.2067","volume":"89","author":"LH Argatoff","year":"1997","unstructured":"Argatoff, L. H., Connors, J. M., Klasa, R. J., Horsman, D. E. & Gascoyne, R. D. Mantle cell lymphoma: a clinicopathologic study of 80 cases. Blood 89, 2067\u20132078 (1997).","journal-title":"Blood"},{"key":"22872_CR2","doi-asserted-by":"publisher","first-page":"18250","DOI":"10.1073\/pnas.1314608110","volume":"110","author":"S Bea","year":"2013","unstructured":"Bea, S. et al. Landscape of somatic mutations and clonal evolution in mantle cell lymphoma. Proc. Natl Acad. Sci. USA 110, 18250\u201318255 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"22872_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.4103\/0377-4929.42503","volume":"51","author":"S Gujral","year":"2008","unstructured":"Gujral, S. et al. A clinicopathologic study of mantle cell lymphoma in a single center study in India. Indian J. Pathol. Microbiol. 51, 315\u2013322 (2008).","journal-title":"Indian J. Pathol. Microbiol."},{"key":"22872_CR4","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.5858\/1999-123-1182-MCL","volume":"123","author":"RC Hankin","year":"1999","unstructured":"Hankin, R. C. & Hunter, S. V. Mantle cell lymphoma. Arch. Pathol. Lab. Med. 123, 1182\u20131188 (1999).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"22872_CR5","first-page":"879","volume":"17","author":"J Kauh","year":"2003","unstructured":"Kauh, J., Baidas, S. M., Ozdemirli, M. & Cheson, B. D. Mantle cell lymphoma: clinicopathologic features and treatments. Oncology 17, 879\u2013891 (2003). 896; discussion 896\u2013878.","journal-title":"Oncology"},{"key":"22872_CR6","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/107327481201900307","volume":"19","author":"BD Shah","year":"2012","unstructured":"Shah, B. D., Martin, P. & Sotomayor, E. M. Mantle cell lymphoma: a clinically heterogeneous disease in need of tailored approaches. Cancer Control 19, 227\u2013235 (2012).","journal-title":"Cancer Control"},{"key":"22872_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1053\/hupa.2002.30221","volume":"33","author":"SH Swerdlow","year":"2002","unstructured":"Swerdlow, S. H. & Williams, M. E. From centrocytic to mantle cell lymphoma: a clinicopathologic and molecular review of 3 decades. Hum. Pathol. 33, 7\u201320 (2002).","journal-title":"Hum. Pathol."},{"key":"22872_CR8","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/1096-8652(200007)64:3<190::AID-AJH9>3.0.CO;2-B","volume":"64","author":"DD Weisenburger","year":"2000","unstructured":"Weisenburger, D. D. et al. Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group. Am. J. Hematol. 64, 190\u2013196 (2000).","journal-title":"Am. J. Hematol."},{"key":"22872_CR9","doi-asserted-by":"publisher","first-page":"38180","DOI":"10.18632\/oncotarget.9500","volume":"7","author":"C Wu","year":"2016","unstructured":"Wu, C. et al. Genetic heterogeneity in primary and relapsed mantle cell lymphomas: impact of recurrent CARD11 mutations. Oncotarget 7, 38180\u201338190 (2016).","journal-title":"Oncotarget"},{"key":"22872_CR10","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1200\/JCO.2016.70.4320","volume":"35","author":"MS Davids","year":"2017","unstructured":"Davids, M. S. et al. Phase I first-in-human study of venetoclax in patients with relapsed or refractory non-Hodgkin lymphoma. J. Clin. Oncol. 35, 826\u2013833 (2017).","journal-title":"J. Clin. Oncol."},{"key":"22872_CR11","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1056\/NEJMoa1715519","volume":"378","author":"CS Tam","year":"2018","unstructured":"Tam, C. S. et al. Ibrutinib plus venetoclax for the treatment of mantle-cell lymphoma. N. Engl. J. Med. 378, 1211\u20131223 (2018).","journal-title":"N. Engl. J. Med."},{"key":"22872_CR12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1056\/NEJMoa1306220","volume":"369","author":"ML Wang","year":"2013","unstructured":"Wang, M. L. et al. Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma. N. Engl. J. Med. 369, 507\u2013516 (2013).","journal-title":"N. Engl. J. Med."},{"key":"22872_CR13","doi-asserted-by":"publisher","first-page":"3362","DOI":"10.1182\/blood-2017-01-763003","volume":"129","author":"MA Anderson","year":"2017","unstructured":"Anderson, M. A. et al. Clinicopathological features and outcomes of progression of CLL on the BCL2 inhibitor venetoclax. Blood 129, 3362\u20133370 (2017).","journal-title":"Blood"},{"key":"22872_CR14","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/annonc\/mdv111","volume":"26","author":"CY Cheah","year":"2015","unstructured":"Cheah, C. Y. et al. Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes. Ann. Oncol. 26, 1175\u20131179 (2015).","journal-title":"Ann. Oncol."},{"key":"22872_CR15","doi-asserted-by":"crossref","unstructured":"Zhang, L. et al. Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma. Sci. Transl. Med. 11, eaau1167, https:\/\/pubmed.ncbi.nlm.nih.gov\/31068440\/ (2019).","DOI":"10.1126\/scitranslmed.aau1167"},{"key":"22872_CR16","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","volume":"168","author":"N McGranahan","year":"2017","unstructured":"McGranahan, N. & Swanton, C. Clonal heterogeneity and tumor evolution: past, present, and the future. Cell 168, 613\u2013628 (2017).","journal-title":"Cell"},{"key":"22872_CR17","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nbt.4091","volume":"36","author":"L Haghverdi","year":"2018","unstructured":"Haghverdi, L., Lun, A. T. L., Morgan, M. D. & Marioni, J. C. Batch effects in single-cell RNA-sequencing data are corrected by matching mutual nearest neighbors. Nat. Biotechnol. 36, 421\u2013427 (2018).","journal-title":"Nat. Biotechnol."},{"key":"22872_CR18","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.1158\/0008-5472.CAN-08-0025","volume":"68","author":"X He","year":"2008","unstructured":"He, X. et al. PIK3IP1, a negative regulator of PI3K, suppresses the development of hepatocellular carcinoma. Cancer Res. 68, 5591\u20135598 (2008).","journal-title":"Cancer Res."},{"key":"22872_CR19","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41416-018-0368-3","volume":"120","author":"M Foltyn","year":"2019","unstructured":"Foltyn, M. et al. The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma. Br. J. Cancer 120, 481\u2013487 (2019).","journal-title":"Br. J. Cancer"},{"key":"22872_CR20","first-page":"1538","volume":"7","author":"G Roos","year":"1993","unstructured":"Roos, G., Brattsand, G., Landberg, G., Marklund, U. & Gullberg, M. Expression of oncoprotein 18 in human leukemias and lymphomas. Leukemia 7, 1538\u20131546 (1993).","journal-title":"Leukemia"},{"key":"22872_CR21","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1038\/onc.2016.510","volume":"36","author":"CH Chen","year":"2017","unstructured":"Chen, C. H. et al. Upregulation of MARCKS in kidney cancer and its potential as a therapeutic target. Oncogene 36, 3588\u20133598 (2017).","journal-title":"Oncogene"},{"key":"22872_CR22","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.bpj.2016.03.001","volume":"110","author":"BP Ziemba","year":"2016","unstructured":"Ziemba, B. P., Burke, J. E., Masson, G., Williams, R. L. & Falke, J. J. Regulation of PI3K by PKC and MARCKS: single-molecule analysis of a reconstituted signaling pathway. Biophys. J. 110, 1811\u20131825 (2016).","journal-title":"Biophys. J."},{"key":"22872_CR23","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1038\/sj.jid.5700909","volume":"127","author":"T Inozume","year":"2007","unstructured":"Inozume, T. et al. Dendritic cells transduced with autoantigen FCRLA induce cytotoxic lymphocytes and vaccinate against murine B-cell lymphoma. J. Invest. Dermatol. 127, 2818\u20132822 (2007).","journal-title":"J. Invest. Dermatol."},{"key":"22872_CR24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1182\/blood-2008-01-131359","volume":"112","author":"FJ Li","year":"2008","unstructured":"Li, F. J. et al. FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia. Blood 112, 179\u2013187 (2008).","journal-title":"Blood"},{"key":"22872_CR25","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.3324\/haematol.2010.025767","volume":"95","author":"SJ Rodig","year":"2010","unstructured":"Rodig, S. J. et al. The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas. Haematologica 95, 2056\u20132062 (2010).","journal-title":"Haematologica"},{"key":"22872_CR26","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ymeth.2015.06.021","volume":"85","author":"A Scialdone","year":"2015","unstructured":"Scialdone, A. et al. Computational assignment of cell-cycle stage from single-cell transcriptome data. Methods 85, 54\u201361 (2015).","journal-title":"Methods"},{"key":"22872_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/bjh.13275","volume":"170","author":"M Furtado","year":"2015","unstructured":"Furtado, M. et al. Ibrutinib-associated lymphocytosis corresponds to bone marrow involvement in mantle cell lymphoma. Br. J. Haematol. 170, 131\u2013134 (2015).","journal-title":"Br. J. Haematol."},{"key":"22872_CR28","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1038\/leu.2014.122","volume":"28","author":"SE Herman","year":"2014","unstructured":"Herman, S. E. et al. Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study. Leukemia 28, 2188\u20132196 (2014).","journal-title":"Leukemia"},{"key":"22872_CR29","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/jcp.1041250303","volume":"125","author":"CE Chandler","year":"1985","unstructured":"Chandler, C. E., Cragoe, E. J. Jr. & Glaser, L. Nerve growth factor does not activate Na+\/H+ exchange in PC12 pheochromocytoma cells. J. Cell Physiol. 125, 367\u2013378 (1985).","journal-title":"J. Cell Physiol."},{"key":"22872_CR30","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nmeth.4236","volume":"14","author":"VY Kiselev","year":"2017","unstructured":"Kiselev, V. Y. et al. SC3: consensus clustering of single-cell RNA-seq data. Nat. Methods 14, 483\u2013486 (2017).","journal-title":"Nat. Methods"},{"key":"22872_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-016-0738-9","volume":"18","author":"A Sethuraman","year":"2016","unstructured":"Sethuraman, A. et al. SMARCE1 regulates metastatic potential of breast cancer cells through the HIF1A\/PTK2 pathway. Breast Cancer Res. 18, 81 (2016).","journal-title":"Breast Cancer Res."},{"key":"22872_CR32","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1073\/pnas.1703931114","volume":"114","author":"ES Sokol","year":"2017","unstructured":"Sokol, E. S. et al. SMARCE1 is required for the invasive progression of in situ cancers. Proc. Natl Acad. Sci. USA 114, 4153\u20134158 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"22872_CR33","doi-asserted-by":"publisher","first-page":"314","DOI":"10.7150\/jca.13332","volume":"7","author":"X Chen","year":"2016","unstructured":"Chen, X., Duan, N., Zhang, C. & Zhang, W. Survivin and tumorigenesis: molecular mechanisms and therapeutic strategies. J. Cancer 7, 314\u2013323 (2016).","journal-title":"J. Cancer"},{"key":"22872_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09447-z","volume":"7","author":"E Kim","year":"2017","unstructured":"Kim, E. et al. TRAF4 promotes lung cancer aggressiveness by modulating tumor microenvironment in normal fibroblasts. Sci. Rep. 7, 8923 (2017).","journal-title":"Sci. Rep."},{"key":"22872_CR35","doi-asserted-by":"publisher","first-page":"54913","DOI":"10.18632\/oncotarget.10798","volume":"7","author":"M Kpetemey","year":"2016","unstructured":"Kpetemey, M., Chaudhary, P., Van Treuren, T. & Vishwanatha, J. K. MIEN1 drives breast tumor cell migration by regulating cytoskeletal-focal adhesion dynamics. Oncotarget 7, 54913\u201354924 (2016).","journal-title":"Oncotarget"},{"key":"22872_CR36","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.tranon.2018.07.002","volume":"11","author":"YF Yang","year":"2018","unstructured":"Yang, Y. F., Pan, Y. H., Tian, Q. H., Wu, D. C. & Su, S. G. CBX1 indicates poor outcomes and exerts oncogenic activity in hepatocellular carcinoma. Transl. Oncol. 11, 1110\u20131118 (2018).","journal-title":"Transl. Oncol."},{"key":"22872_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0656-1","volume":"16","author":"C Zhang","year":"2017","unstructured":"Zhang, C., Xu, B., Lu, S., Zhao, Y. & Liu, P. HN1 contributes to migration, invasion, and tumorigenesis of breast cancer by enhancing MYC activity. Mol. Cancer 16, 90 (2017).","journal-title":"Mol. Cancer"},{"key":"22872_CR38","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.molcel.2013.07.014","volume":"51","author":"L Zhang","year":"2013","unstructured":"Zhang, L. et al. TRAF4 promotes TGF-beta receptor signaling and drives breast cancer metastasis. Mol. Cell 51, 559\u2013572 (2013).","journal-title":"Mol. Cell"},{"key":"22872_CR39","doi-asserted-by":"crossref","unstructured":"Wheatley, S. P. & Altieri, D. C. Survivin at a glance. J. Cell Sci. 132, jcs223826 https:\/\/pubmed.ncbi.nlm.nih.gov\/30948431\/ (2019).","DOI":"10.1242\/jcs.223826"},{"key":"22872_CR40","doi-asserted-by":"crossref","unstructured":"Zhao, H. B., Zhang, X. F., Wang, H. B. & Zhang, M. Z. Migration and invasion enhancer 1 (MIEN1) is overexpressed in breast cancer and is a potential new therapeutic molecular target. Genet. Mol. Res. 16, 1, https:\/\/pubmed.ncbi.nlm.nih.gov\/28198505\/ (2017).","DOI":"10.4238\/gmr16019380"},{"key":"22872_CR41","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.3727\/096504017X14876227286564","volume":"25","author":"K Liu","year":"2017","unstructured":"Liu, K. et al. TRAF4 regulates migration, invasion, and epithelial-mesenchymal transition via PI3K\/AKT signaling in hepatocellular carcinoma. Oncol. Res. 25, 1329\u20131340 (2017).","journal-title":"Oncol. Res."},{"key":"22872_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-018-0633-9","volume":"18","author":"EG Weagel","year":"2018","unstructured":"Weagel, E. G. et al. Membrane expression of thymidine kinase 1 and potential clinical relevance in lung, breast, and colorectal malignancies. Cancer Cell Int. 18, 135 (2018).","journal-title":"Cancer Cell Int."},{"key":"22872_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-8-106","volume":"8","author":"S Blenk","year":"2008","unstructured":"Blenk, S. et al. Explorative data analysis of MCL reveals gene expression networks implicated in survival and prognosis supported by explorative CGH analysis. BMC Cancer 8, 106 (2008).","journal-title":"BMC Cancer"},{"key":"22872_CR44","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","volume":"3","author":"A Rosenwald","year":"2003","unstructured":"Rosenwald, A. et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 3, 185\u2013197 (2003).","journal-title":"Cancer Cell"},{"key":"22872_CR45","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/hon.2188","volume":"34","author":"C Yoo","year":"2016","unstructured":"Yoo, C. et al. Serum beta-2 microglobulin as a prognostic biomarker in patients with mantle cell lymphoma. Hematol. Oncol. 34, 22\u201327 (2016).","journal-title":"Hematol. Oncol."},{"key":"22872_CR46","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nrc1527","volume":"5","author":"FT Liu","year":"2005","unstructured":"Liu, F. T. & Rabinovich, G. A. Galectins as modulators of tumour progression. Nat. Rev. Cancer 5, 29\u201341 (2005).","journal-title":"Nat. Rev. Cancer"},{"key":"22872_CR47","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1681\/ASN.2013070773","volume":"25","author":"CS Huang","year":"2014","unstructured":"Huang, C. S. et al. Galectin-1 upregulates CXCR4 to promote tumor progression and poor outcome in kidney cancer. J. Am. Soc. Nephrol. 25, 1486\u20131495 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"22872_CR48","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1128\/MCB.00348-14","volume":"34","author":"H de la Fuente","year":"2014","unstructured":"de la Fuente, H. et al. The leukocyte activation receptor CD69 controls T cell differentiation through its interaction with galectin-1. Mol. Cell Biol. 34, 2479\u20132487 (2014).","journal-title":"Mol. Cell Biol."},{"key":"22872_CR49","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.3389\/fimmu.2018.03018","volume":"9","author":"F Eckert","year":"2018","unstructured":"Eckert, F. et al. Potential role of CXCR4 targeting in the context of radiotherapy and immunotherapy of cancer. Front. Immunol. 9, 3018 (2018).","journal-title":"Front. Immunol."},{"key":"22872_CR50","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1182\/blood-2018-99-116756","volume":"132","author":"XH Zhao","year":"2018","unstructured":"Zhao, X. H. et al. Targeting kinome reprogramming for overcoming ibrutinib-resistance (IR) in mantle cell lymphoma (MCL). Blood 132, 2651 (2018).","journal-title":"Blood"},{"key":"22872_CR51","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0002-9440(10)63140-9","volume":"164","author":"A Martinez","year":"2004","unstructured":"Martinez, A. et al. Nuclear survivin expression in mantle cell lymphoma is associated with cell proliferation and survival. Am. J. Pathol. 164, 501\u2013510 (2004).","journal-title":"Am. J. Pathol."},{"key":"22872_CR52","doi-asserted-by":"publisher","first-page":"68833","DOI":"10.18632\/oncotarget.11932","volume":"7","author":"S Sharma","year":"2016","unstructured":"Sharma, S. et al. Identification of a structurally novel BTK mutation that drives ibrutinib resistance in CLL. Oncotarget 7, 68833\u201368841 (2016).","journal-title":"Oncotarget"},{"key":"22872_CR53","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cell.2020.03.048","volume":"181","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. Single-cell analyses inform mechanisms of myeloid-targeted therapies in colon cancer. Cell 181, 442\u2013459 e429 (2020).","journal-title":"Cell"},{"key":"22872_CR54","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/s41591-018-0078-7","volume":"24","author":"P Savas","year":"2018","unstructured":"Savas, P. et al. Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis. Nat. Med. 24, 986\u2013993 (2018).","journal-title":"Nat. Med."},{"key":"22872_CR55","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411\u2013420 (2018).","journal-title":"Nat. Biotechnol."},{"key":"22872_CR56","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","volume":"175","author":"M Sade-Feldman","year":"2018","unstructured":"Sade-Feldman, M. et al. Defining T cell states associated with response to checkpoint immunotherapy in melanoma. Cell 175, 998\u20131013 e1020 (2018).","journal-title":"Cell"},{"key":"22872_CR57","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","volume":"169","author":"C Zheng","year":"2017","unstructured":"Zheng, C. et al. Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing. Cell 169, 1342\u20131356 e1316 (2017).","journal-title":"Cell"},{"key":"22872_CR58","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.cell.2018.09.006","volume":"175","author":"L Jerby-Arnon","year":"2018","unstructured":"Jerby-Arnon, L. et al. A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade. Cell 175, 984\u2013997 e924 (2018).","journal-title":"Cell"},{"key":"22872_CR59","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nmeth.4402","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu, X. et al. Reversed graph embedding resolves complex single-cell trajectories. Nat. Methods 14, 979\u2013982 (2017).","journal-title":"Nat. Methods"},{"key":"22872_CR60","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1093\/nar\/gkw430","volume":"44","author":"Z Ji","year":"2016","unstructured":"Ji, Z. & Ji, H. TSCAN: pseudo-time reconstruction and evaluation in single-cell RNA-seq analysis. Nucleic Acids Res. 44, e117 (2016).","journal-title":"Nucleic Acids Res."},{"key":"22872_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-018-4772-0","volume":"19","author":"K Street","year":"2018","unstructured":"Street, K. et al. Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics. BMC Genomics 19, 477 (2018).","journal-title":"BMC Genomics"},{"key":"22872_CR62","doi-asserted-by":"publisher","unstructured":"Cannoodt, Robrecht et al. SCORPIUS improves trajectory inference and identifies novel modules in dendritic cell development. Preprint at BioRxiv https:\/\/doi.org\/10.1101\/079509 (2016).","DOI":"10.1101\/079509"},{"key":"22872_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14, 7 (2013).","journal-title":"BMC Bioinform."},{"key":"22872_CR64","doi-asserted-by":"publisher","unstructured":"Wang, Yuanxin et al. iTALK: an R package to characterize and illustrate intercellular communication. Preprint at BioRxiv https:\/\/doi.org\/10.1101\/507871 (2019).","DOI":"10.1101\/507871"},{"key":"22872_CR65","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1158\/1535-7163.MCT-18-0478","volume":"18","author":"C Li","year":"2018","unstructured":"Li, C. J. et al. Pleiotropic action of novel Bruton\u2019s tyrosine kinase inhibitor BGB-3111 in mantle cell lymphoma. Mol. Cancer Ther. 18, 267\u2013277 (2018).","journal-title":"Mol. Cancer Ther"},{"key":"22872_CR66","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1158\/1078-0432.CCR-17-3004","volume":"24","author":"LV Pham","year":"2018","unstructured":"Pham, L. V. et al. Strategic therapeutic targeting to overcome venetoclax resistance in aggressive B-cell lymphomas. Clin. Cancer Res. 24, 3967\u20133980 (2018).","journal-title":"Clin. Cancer Res."},{"key":"22872_CR67","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"22872_CR68","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.806","volume":"43","author":"MA DePristo","year":"2011","unstructured":"DePristo, M. A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43, 491\u2013498 (2011).","journal-title":"Nat. Genet."},{"key":"22872_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-016-1190-7","volume":"17","author":"IF do Valle","year":"2016","unstructured":"do Valle, I. F. et al. Optimized pipeline of MuTect and GATK tools to improve the detection of somatic single nucleotide polymorphisms in whole-exome sequencing data. BMC Bioinform. 17, 341 (2016).","journal-title":"BMC Bioinform."},{"key":"22872_CR70","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1093\/bioinformatics\/btp394","volume":"25","author":"K Ye","year":"2009","unstructured":"Ye, K., Schulz, M. H., Long, Q., Apweiler, R. & Ning, Z. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics 25, 2865\u20132871 (2009).","journal-title":"Bioinformatics"},{"key":"22872_CR71","doi-asserted-by":"publisher","first-page":"e1003665","DOI":"10.1371\/journal.pcbi.1003665","volume":"10","author":"CA Miller","year":"2014","unstructured":"Miller, C. A. et al. SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution. PLoS Comput. Biol. 10, e1003665 (2014).","journal-title":"PLoS Comput. Biol."},{"key":"22872_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-016-3195-z","volume":"17","author":"CA Miller","year":"2016","unstructured":"Miller, C. A. et al. Visualizing tumor evolution with the fishplot package for R. BMC Genomics 17, 880 (2016).","journal-title":"BMC Genomics"},{"key":"22872_CR73","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1126\/science.1256930","volume":"346","author":"J Zhang","year":"2014","unstructured":"Zhang, J. et al. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science 346, 256\u2013259 (2014).","journal-title":"Science"},{"key":"22872_CR74","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/biostatistics\/kxh008","volume":"5","author":"AB Olshen","year":"2004","unstructured":"Olshen, A. B., Venkatraman, E. S., Lucito, R. & Wigler, M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 5, 557\u2013572 (2004).","journal-title":"Biostatistics"},{"key":"22872_CR75","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/annonc\/mdu479","volume":"26","author":"F Favero","year":"2015","unstructured":"Favero, F. et al. Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data. Ann. Oncol. 26, 64\u201370 (2015).","journal-title":"Ann. Oncol."}],"updated-by":[{"DOI":"10.1038\/s41467-024-52013-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:00:00Z","timestamp":1728259200000}}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22872-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22872-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22872-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T03:04:59Z","timestamp":1728356699000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22872-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,17]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["22872"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-22872-z","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,17]]},"assertion":[{"value":"14 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41467-024-52013-1","URL":"https:\/\/doi.org\/10.1038\/s41467-024-52013-1","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2877"}}